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Department of Chemistry, University of Mysore, Manasagangotri, Mysuru, Karnataka, India.
One titrimetric and two spectrophotometric methods are proposed for the determination of 
diethylcarbamazine citrate (DEC) in bulk drug and in formulations using potassium iodate and potassium 
iodide as reagent. The methods employ the well-known analytical reaction between iodate and iodide in 
the presence of acid. In titrimetry (method A), the drug was treated with a measured excess of thiosulfate 
in the presence of unmeasured excess of iodate-iodide mixture and after a standing time of 10 min, the 
surplus thiosulfate was determined by back titration with iodine towards starch end point. Titrimetric 
assay is based on a 1:3 reaction stoichiometry between DEC and iodine and the method is applicable 
over 2.0–10.0 mg range. The liberated iodine is measured spectrophotometrically at 370 nm (method B) 
or the iodine-starch complex measured at 570 nm (method C). In both methods, the absorbance is found 
to be linearly dependent on the concentration of iodine, which in turn is related to DEC concentration. 
The calibration curves are linear over 2.5-50 and 2.5-30 µg mL-1 DEC for method B and method C, 
respectively. The calculated molar absorptivity and Sandell sensitivity values were 6.48×103 L mol-1 
cm-1 and 0.0604 µg cm-2, respectively, for method B, and their respective values for method C are  
9.96×103 L mol-1 cm-1 and 0.0393 µg cm-2. The intra-day and inter-day accuracy and precision studies 
were carried out according to the ICH guidelines. The methods were successfully applied to the analysis 
of DEC formulations.
Uniterms: Diethylcarbamazine citrate/determination. Titrimetry/quantitative analysis. Spectrophotometry/
quantitative analysis. Pharmaceutical formulations/analysis.
Propõem-se titulação e dois métodos espectrofotométricos para a determinação de citrato de 
dietilcarbamazina (DEC) a granel e em suas formulações, usando iodato de potássio e iodeto de potássio 
como reagente. Os métodos utilizam a reação analítica conhecida entre iodato e iodeto, na presença de 
ácido. Na titulometria (Método A), o fármaco foi tratado com excesso medido de tiossulfato, na presença 
de excesso não medido de mistura iodato-iodeto e, depois de um tempo de repouso de 10 min, o excesso 
de tiossulfato foi determinado por titulação de retorno com iodo até o ponto final com amido. A titulação 
é baseada em reação com estequiometria 1:3 entre DEC e iodo e o método é aplicável na faixa de 2.0-
10.0 mg. O iodo liberado é medido espectrofotometricamente a 370 nm (método B) ou o complexo 
de iodo-amido medido a 570 nm (método C). Em ambos os métodos, a absorvância é considerada 
linearmente dependente da concentração de iodo, a qual, por sua vez, está relacionada à concentração 
de DEC. As curvas de calibração são lineares para concentrações de DEC de 2.5-50 e 2.5-30 mg mL- 1 
para o método B e para o método C, respectivamente. A absortividade molar calculada e os valores de 
sensibilidade Sandel foram 6.48×103 L mol-1 cm- 1 e 0.0604 ug cm-2, respectivamente, para o método B, 
e os seus respectivos valores para o método C são 9.96×103 L mol-1 cm-1 e 0.0393 mg cm-2. Os estudos 
de exatidão e precisão intra-dia e inter-dia foram realizados de acordo com as diretrizes da ICH. Os 
métodos foram aplicados com sucesso na análise de formulações de DEC.
Unitermos: Citrato de dietilcarbamazina/determinação. Titulometria/análise quantitativa. 
Espectrofotometria/análise quantitativa. Formulações farmacêuticas/análise.
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INTRODUCTION
Diethylcarbamazine citrate (DEC) [Figure 1], 
chemically known as [N,N-diethyl-4-methyl-1-
piperazinecarboxamide citrate] is an anthelmintic agent 
used in the treatment of filarial infections caused by a host 
of organisms commonly found in the tropics (Swinyard, 
1990). It is also the alternative drug of choice in Onchocerca 
volvulus infections and tropical eosinophilia (Adkiwu, 
Ofokansi, Attama, 1999). The drug is official in British 
Pharmacopoeia [BP] (1988), which describes a non-
aqueous titration method for its determination and also 
official in the United States Pharmacopoeia [USP] (United 
States Pharmacopoeia, Monographs), which uses a liquid 
chromatographic technique with phosphate buffer system 
for the assay.
Other than these official methods, a variety of 
techniques have been reported for the determination of 
DEC in pharmaceutical dosage forms, and include gas 
chromatography [GC] (Ramana, Raghuveer, Khadgapathi, 
1986; Nene, Anjaneyalu, Rajagopalan, 1984; Pfaff, 
Gayral, Mahuzier, 1978; Joseph, Lawrence, 2001), high 
performance liquid chromatography [HPLC] (Mathew, 
Kalyanasundaram, 2001; Reddy et al., 2011; Krishna 
Vamsi et al., 2012), proton magnetic resonance [PMR] 
spectroscopy (El-Obeid, 1984, Jezzy et al., 1996), 
DC polarography analysis (Walash et al., 1985), ion 
selective electrode potentiometry (Campbell et al., 1980) 
and titrimetry (Abigail et al., 2011; Bhanumathi et al., 
1981). However, many of the reported methods for DEC, 
particularly, the chromatographic methods are complex, 
requiring expensive instrumental set up and skilled 
operator which are not always found in laboratories of 
developing and under developed countries. Thus, the 
need for a simple, selective and low-cost method is 
obvious, especially for routine quality control analysis of 
pharmaceuticals containing DEC.
Several spectrophotometric methods based on 
diverse chemical reactions are found in the literature 
for DEC. Charge-transfer complex formed with iodine 
was used by Wahbi, El-Obeid, Gad-Kariem (El-Obeid, 
Gad-Kariem, 1986), for the assay of 1-6 μg mL–1 DEC 
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FIGURE 1 - Structure of diethylcarbamazine citrate.
in tablets. Chloranilic acid has been employed by two 
groups of workers (Rizk, Walash, Ibrahim, 1984; Michael, 
Kenneth, Anthony, 1999) as CT complexing agent for 
the assay of drug in pharmaceuticals based on the same 
type of reaction. In a method reported by Basu and Dutta 
(1961), the ion associate formed by DEC with ammonium 
reineckate at pH 3.5 was filtered, dissolved in acetone and 
absorbance measured at 525 nm. The colored condensation 
product (Refaat et al., 1987) formed by malonic acid with 
acetic anhydride in the presence of DEC was measured at 
333 nm facilitating the assay of the drug in dosage forms. 
In a similar method (Bulbule, Kasture, Wadodkar, 1981), 
the base form of the drug was reacted with malonic acid 
and acetic anhydride at 80 °C for 30 min and the resulting 
condensation product was measured at 334 nm. The yellow 
colored condensation product (Bhuee et al., 1981) formed 
by an acetous solution of DEC with acetic anhydride-
pyridine mixture was measured at 428 nm and used for 
the determination of DEC in 10-100 μg mL–1 range in 
commercial tablets.
There are three reports on the use of ion-pair 
complexation reactions for the spectrophotometric 
assay of DEC. Rao and Subramanyam (1970) employed 
bromophenol blue at acidic pH as the ion pair complexing 
agent for the determination of the drug in tablets and 
biological fluids. The drug in tablets, syrups and parenterals 
was determined by extracting the ion-pair complex formed 
with bromocresol green (Vadodaria, Vora, Mukherji, 1968) 
at pH 4.6 with chloroform. The colored complexes of the 
drug with Fast green FCF at pH 5.0 and orange II in 0.1 M 
HCl were successfully employed by Sastry et al. (1988), for 
the determination of DEC in bulk drug and pharmaceutical 
preparations by extractive spectrophotometry.
The reported spectrophotometric methods suffer 
from one or the other disadvantage such as poor sensitivity 
and narrow linear range (Michael, Kenneth, Anthony, 
1999), tedious and time-consuming steps like precipitation, 
filtration and washing (Basu, Dutta, 1961), heating (Refaat 
et al., 1987; Bulbule, Kasture, Wadodkar, 1981; Bhuee et 
al., 1981). The extraction methods (Rao, Subrahmanyam, 
1970; Vadodaria, Vora, Mukherji, 1968; Sastry et al., 
1988) though sensitive suffer from disadvantages like 
laborious liquid-liquid extraction step, critical pH 
adjustment, critical dependence on pH of the aqueous 
phase and the aqueous-organic phase’s ratio. Additionally, 
incomplete extraction of the analyte may lead to erratic 
results. Hence, there is a need for developing a method 
free from such disadvantages.
The aim of the present study was directed at 
developing and validating simple, rapid, sensitive, cost-
effective titrimetric and two spectrophotometric methods 
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using iodate and iodide as reagents. Iodide of the mixture 
present is oxidized by iodate in an amount equivalent to 
the COOH group present in citrate in DEC to iodine and 
the liberated iodine is determined. The methods were 
successfully applied to quantify DEC in pharmaceutical 
formulations.
MATERIAL AND METHODS
Apparatus
A Systronics model 166 digital spectrophotometer 
(Systronics, Ahmedabad, Gujarat, India) with matched 
1-cm quartz cells was used for absorbance measurements.
Reagents and standards
All chemicals used were of analytical reagent grade 
and distilled water was used to prepare solutions. 
Potassium iodate
A high purity grade of the chemical (Merck, Mumbai, 
India) was used. A saturated solution of potassium iodate 
was prepared by stirring approximately 20 g of the chemical 
in a beaker containing 100 mL water with the help of 
magnetic stirrer for 60 minutes. The solution was decanted 
and filtered using quantitative filter paper.
Potassium iodide
A saturated solution of potassium iodide (Merck, 
Mumbai, India) was prepared just before use in order to 
prevent atmospheric oxidation to iodide.
Sodium thiosulphate
A 0.01 N sodium thiosulphate (S.D. Fine Chem., 
Mumbai, India) was prepared by dissolving 1.25 g in 
500 mL water and standardized against 0.01N potassium 
dichromate (Vogel, 1961).
Iodine solution
A 0.01 N iodine solution (Merck, Mumbai, India) 
was prepared by dissolving 5 g of iodate-free potassium 
iodide in 30-40 mL of water in a glass stoppered 500 mL 
calibrated flask. Weighed out 0.63 g of analytical reagent 
(AR) grade or resublimed iodine on a watch glass and 
transferred into a flask containing concentrated potassium 
iodide by means of a small dry funnel, inserted the glass 
stopper into the flask, and shaken well in the cold condition 
until all the iodine has dissolved. Allowed the solution 
to acquire room temperature, and made up to mark with 
distilled water in a 500 mL calibrated flask (Vogel, 1961).
Saturated Borax
Approximately 30 g of borax (S.D. Fine Chem., 
Mumbai, India) were dissolved in 100 mL water and 
stirred with the help of magnetic stirrer for 15 minutes. The 
solution was decanted and filtered. The pH of the solution 
was between 8 and 9.
1% starch
Made a paste of 1 g of the soluble starch (Potato 
starch, Loba Chemie, Mumbai, India) with a little water, 
and poured the paste with constant stirring, into 100 mL of 
boiling water, and boiled for 1 min., allowed the solution 
to cool before use and prepared afresh every day (Vogel, 
1961).
Standard drug solution
Pharmaceutical grade DEC (99.7 per cent pure) was 
procured from Inga Laboratories Pvt. Ltd., Mumbai, India, 
and was used as received. Banocide forte tablets (Glaxo 
Smith Kline Pharma. Ltd., Nashik, India) and Banocide 
syrup (Glaxo Smith Kline Pharma. Ltd., Bangalore, India) 
both were purchased from local commercial stores.
A stock standard solution equivalent to 1 mg mL-1 
DEC for method A was prepared by dissolving 250 mg of 
pure drug in water and diluting to 250 mL in calibrated 
flask with water. The stock solution was diluted 
appropriately to get working concentration of 100 mg mL-1 
with water for spectrophotometric methods.
Recommended procedures
Method A
A 10 mL aliquot of pure DEC solution containing 
2-10 mg of DEC was taken in an Erlenmeyer flask. Five 
mL each of saturated solutions of KIO3 and KI followed 
by 10 mL thiosulfate (accurately measured) were added 
and the flask was stoppered and let stand for 10 min with 
occasional swirling. Finally, 1 mL of 1% starch indicator 
was added and unreacted thiosulfate was titrated against 
standard iodine solution until the decoloration of blue 
color.
The amount of DEC was calculated from the 
following formula:
 W{(B – S) × M × C}Amount (mg) =
n
where, B= volume of iodine consumed in the blank 
titration, mL; S= volume of iodine consumed in the sample 
titration, mL; Mw= relative molecular mass of DEC; C= 
molar concentration of thiosulfat; n= number of moles of 
iodine reacting with each mole of DEC.
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Method B
Varying aliquots (0.25-5.0 mL) of 100 µg mL-1 DEC 
was added in to a series of 10 mL calibrated flasks by 
means of micro burette. To each flask, 1.5 mL of KIO3 and 
1 mL of KI were added flasks stoppered, content mixed 
and let stand for 15 min. Then 1 mL of saturated borax was 
added and made up to the mark with water. Absorbance 
of each solution was measured at 370 nm against reagent 
blank.
Method C
Different volumes (0.2-3.0 mL) of 100 µg mL-1 DEC 
were taken in a series of 10 mL calibrated flasks. One mL 
each of saturated KIO3 and KI solutions were added, flasks 
were stoppered and content mixed. The flasks were let 
stand for 15 min before adding 1 mL of saturated borax 
and 1 mL of 1% starch to each flask and finally made up 
to 10 mL with water. Absorbance of each solution was 
measured at 570 nm against reagent blank.
Standard  graph was  prepared by p lo t t ing 
the absorbance versus drug concentration, and the 
concentration of the unknown was computed from the 
respective regression equation.
Procedure for tablets
Twenty tablets were weighed accurately and ground 
into a fine powder. An accurately weighed amount of 
the powdered tablet equivalent to 100 mg of DEC was 
transferred into a 100 mL calibrated flask. Sixty mL water 
was added and the content was shaken thoroughly for 15-
20 min to extract the drug into the liquid phase; the volume 
was finally diluted to the mark with water, mixed well and 
filtered using a Whatman No. 42 filter paper. An aliquot of 
the filtrate (1 mg mL-1 DEC) was used for method A and 
diluted to required concentrations and used for the assay 
in method B and method C as described above.
Procedure for syrup
The content of five 100 mL syrup bottles was pooled 
and 5 mL syrup containing 120 mg DEC was taken and its 
solution prepared as described in ‘procedure for tablets’. 
This 1.2 mg mL-1 DEC syrup extract was further diluted to 
get working standard solution of 100 mg mL-1 for method 
B and method C with water and analyzed by taking an 
appropriate volume in all the methods.
Procedure for the analysis of placebo blank and 
synthetic mixture
A placebo blank containing starch (45 mg), acacia 
(35 mg), sodium citrate (40 mg), hydroxyl cellulose 
(45 mg), magnesium stearate (50 mg), talc (40 mg) and 
sodium alginate (35 mg) was prepared by mixing all the 
components into a homogeneous mixture. A 100 mg of the 
placebo blank was accurately weighed and its solution was 
prepared as described under ‘tablets’, and then subjected 
to analysis by following the general procedures.
To 50 mg of the placebo blank of the composition 
described above, 100 mg of DEC was added and 
homogenized, transferred to a 100 mL calibrated flask and 
the solution was prepared as described under “Procedure 
for tablets”, and then subjected to analysis by the 
procedure described above. This analysis was performed 
to study the interference by excipients normally present 
in tablet preparation.
RESULTS AND DISCUSSION
Preliminary experiments showed that DEC is 
sufficiently acidic to release iodine from iodate-iodide 
mixture allowing the titrimetric and spectrophotometric 
determination of drug. Iodide present is oxidized by iodate 
in an amount equivalent to the COOH group present 
in citrate in DEC to iodine and the liberated iodine is 
determined. In titrimetry, the liberated iodine was reacted 
with a measured excess of thiosulphate and residual 
reductant was titrated with iodine and the end point being 
located visually with starch, while in spectrophotometry, 
it was determined by two different color reactions.
Method development
Method A
The quantitative nature of the reaction between 
DEC and iodate-iodide reagent was checked by treating 
2.0-10.0 mg of drug with an excess of reagent and 
determining the iodine released. For the range studied 
(2.0-10.0 mg), 5.0 mL each of saturated solution of 
iodate and iodide and reaction time of 10 min were found 
adequate. The end point was located visually using starch. 
The reaction stoichiometry is 1:3 (drug: liberated iodine), 
the COOH group in the citrate is acidic enough to liberate 
iodine. 
IO3ˉ + 5I ˉ + 6H+ (DEC) → 3I2 + 3H2O
I2 + 3Na2S2O3 (excess) → 2NaI + Na2S4O6 + unreacted Na2S2O3
unreacted Na2S2O3 + starch > < Iodine
Method B and method C
Absorbance of the liberated iodine or starch-iodine 
complex was measured at 370 or 570 nm as deduced from 
the absorption spectra of the colored species (Figure 2a 
and 2b). In both methods, the reaction was relatively fast 
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in the beginning and iodine continued to be liberated 
even after 15 min. Since most of the iodine was liberated 
within 15 min, the reaction was stopped by adding borax 
to the reaction mixture after a standing time of 15 min. 
The absorbance remained constant for 25 and 45 min in 
method B and method C, respectively. Attempts to hasten 
the reaction by heating were unsuccessful owing to the 
volatility of iodine and dissociation of iodine-starch 
complex at elevated temperature.
The possible reaction schemes responsible for 
change in absorbance as a function of DEC concentration 
are represented below:
IO3ˉ + 5Iˉ + 6H+ (DEC) → 3I2 + 3H2O 
(Method B: measured at 370 nm)
I2 + Starch → I2-Starch complex 
(Method C: measured at 570 nm)
VALIDATION PROTOCOL
Linearity, detection and quantification limits
Under the optimum conditions, a linear relation was 
obtained between absorbance and concentration of DEC in 
the ranges given in Table I. The calibration graph in each 
instance is described by the equation:
Y = a + b X
where Y = absorbance, a = intercept, b = slope and 
X = concentration in µg mL-1). The correlation coefficient, 
intercept and slope for the calibration data are summarized 
in Table I. Sensitivity parameters such as apparent molar 
absorptivity and Sandell sensitivity values, the limits of 
detection (LOD) and quantification (LOQ) are calculated 
as per the current ICH guidelines (ICH guidelines, 1996) 
and compiled in Table I. LOD and LOQ were calculated 
according to the same guidelines using the following 
formulae:
3.3
LOD
S
σ×
=    &   10LOQ
S
σ×
=
where σ is the standard deviation of six reagent blank 
determinations and s is the slope of the calibration curve, 
also molar absorptivity (ε) and Sandell sensitivity (SS) 
were calculated using the relation; 
3
W
ΔA × M × 10
ε =
ppm
   &   
9
W
0.001 × M ×10
SS =
ε × 1000
 
where DA is the change in absorbance, Mw is the molecular 
weight of DEC and ppm is the concentration of DEC.
Selectivity
The results obtained from placebo blank and synthetic 
mixture analyses revealed that inactive ingredients used 
in the tablet preparation did not interfere in the assay of 
active ingredient. The absorbance values obtained from 
the placebo blank solution were almost equal to the 
absorbance of the blank which revealed no interference 
from the adjuvants. To study the role of additives added 
to the synthetic sample, the analysis of synthetic mixture 
solution prepared as described earlier yielded percent 
recoveries of 98.9±2.13, 99.2±1.36 and 102.31±1.29 (n=5) 
for method A, method B, and method C, respectively. This 
demonstrates the accuracy as well as the precision of the 
proposed methods and complements the findings of the 
placebo blank analysis with respect to selectivity.
Precision
The precision of the method was calculated in terms 
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FIGURE 2- (a) Absorption spectra of DEC-iodide complex () 
[20 mg mL-1 DEC] and blank (-); (b) Absorption spectra of DEC-
iodine-starch complex () [20 mg mL-1 DEC] and blank ()
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of intermediate precision (intra-day and inter-day) (ICH 
guidelines, 1996). Three different concentration of DEC 
were analyzed in seven replicates during the same day 
(intra-day precision) and five consecutive days (inter-day 
precision). The RSD (%) values of intra-day and inter-day 
studies showed that the precision was good (Table II).
Accuracy
The accuracy of an analytical method expresses 
the closeness between the reference value and the found 
value. Accuracy was evaluated as percentage relative 
error between the measured concentrations and taken 
concentrations for DEC. The results obtained are compiled 
in Table II and show that the accuracy is satisfactory for 
all the methods.
Application to analysis of tablets and syrup
The proposed methods were applied to determine 
DEC in one brand each of tablets and syrup. The results 
were statically compared with those obtained by the official 
TABLE I - Sensitivity and regression parameters of spectrophotometric methods
Parameter Method B Method C
lmax, nm 370 570
Color stability, min. ≥ 20 ≥ 60
Linear range, µg mL-1 2.5–50 2.5–30
Molar absorptivity (ε), L mol-1 cm-1 6.48×103 9.96×103
Sandell sensitivity*, µg cm-2 0.0604 0.0393
Limit of detection (LOD), mg mL-1 0.25 0.11
Limit of quantification (LOQ), mg mL-1 0.75 0.33
Regression equation, Y**
Intercept (a) 0.0126 0.0786
Slope (b) 0.0169 0.0337
Standard deviation of a (Sa) 9.98×10-2 9.98×10-2
Standard deviation of b (Sb) 2.24×10-3 3.98×10-3
Regression coefficient (r) 0.9974 0.9939
*Limit of determination as the weight in µg mL-1 of solution, which corresponds to an absorbance of A = 0.001 measured in a 
cuvette of cross-sectional area 1 cm2 and l = 1 cm.  **Y=a+bX, Where Y is the absorbance, X is concentration in µg mL-1, a is 
intercept and b is slope.
TABLE II - Evaluation of Intra-day and inter-day accuracy and precision
Method *DEC Taken
Intra-day accuracy and precision (n=7) Inter-day accuracy and precision (n=7)
*DEC 
Founda 
RSDb 
%
REc 
%
*DEC  
found
RSDb 
%
REc 
%
A
3.0 2.95 1.02 1.67 2.93 1.54 2.33
6.0 5.89 1.76 1.73 5.81 2.58 3.26
9.0 8.89 0.95 1.11 9.11 1.29 1.22
B
10 9.83 1.69 1.73 9.78 2.46 2.76
20 19.71  1.44 0.95 19.65 1.74 3.54
30 29.43  1.88 1.54 29.14 2.85 3.26
C
15 14.79 1.54 1.40 14.71 1.49 1.94
20 19.69 0.97 1.55 19.63 2.13 1.85
25 24.72 1.29 1.12 24.69 1.81 1.24
DEC-diethylcarbamazine citrate. *mg in method A and µg mL-1 in methods B and C; a Mean value of 7 determinations; b Relative 
standard deviation (%); c Relative error (%).
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TABLE III - Results of analysis of formulations by the proposed methods
Formulation 
analyzed Label claim
Found* (Percent of label claim±SD)
Official method
Proposed methods
Method A Method B Method C
Banocide forte 
tablets 100 mg per tablet 98.2±1.63
99.1±1.32 98.9±1.25 98.6±1.65
t = 0.96 t = 0.76 t = 0.39
F = 1.52 F = 1.7 F = 1.02
Banocide syrup 120 mg per 5 mL 101.2±1.29
102.7±1.31 101.6±1.63 101.9±1.7
t = 1.82 t = 0.43 t = 0.73
F = 1.03 F = 1.6 F = 1.74
*Mean value of five determinations. Tabulated t-value at the 95% confidence level is 2.77. Tabulated F-value at the 95% confidence 
level is 6.39.
     
TABLE IV - Results of recovery study via standard addition technique
Method Formulation studied *DEC in tablet *Pure DEC added Total found
*Pure DEC 
recovereda 
Percent±SD
A
Banocide forte 
tablets
2.97 
2.97 
2.97
1.5 
3.0 
4.5
4.17 
5.73 
7.30
99.2±1.34 
100.6±1.29 
101.4±1.18
Banocide syrup
3.08 
3.08 
3.08
1.5 
3.0 
4.5
4.63 
6.23 
7.70
101.2±1.27 
102.5±0.93 
101.6±1.17
B
Banocide forte 
tablets
9.89 
9.89 
9.89
5.0 
10.0 
15.0
15.15 
19.67 
24.79
101.8±1.36 
98.9±1.63 
99.6±1.54
Banocide syrup
10.16 
10.16 
10.16
5.0 
10.0 
15.0
15.48 
20.54 
25.46
102.1±1.81 
101.9±0.99 
101.2±1.36
C
Banocide forte 
tablets
9.86 
9.86 
9.86
5.0 
10.0 
15.0
15.06 
19.78 
24.96
101.4±1.45 
99.6±1.29 
100.4±1.54
Banocide syrup
10.19 
10.19 
10.19
5.0 
10.0 
15.0
15.60 
20.57 
25.52
102.7±1.82 
101.9±0.79 
101.3±1.59
*mg in method A and µg mL-1 in methods B and C; aMean value of three determinations.
British Pharmacopoeia (1988) method, which describes a 
non-aqueous titration method for its determination for 
accuracy and precision by applying the Student’s t-test 
and variance ratio F-test. Statistical analysis of the results 
using Student’s t-test for accuracy and F-test for precision 
revealed no significant difference between the proposed 
methods and the official method at the 95% confidence 
level with respect to accuracy and precision (Table III).
The accuracy and validity of the proposed methods 
were further ascertained by performing recovery studies. 
Pre-analyzed tablet powder was spiked with pure DEC at 
three concentration levels (50,100 and 150 % of that in 
tablet powder) and the total was found by the proposed 
methods. In all cases, the added DEC recovery percentage 
values ranged 98.9-102.7 with a standard deviation of 0.79-
1.82. The results of this study given in Table IV indicated 
that the recovery was good, and that the co-formulated 
substances did not interfere in the determination.
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CONCLUSIONS
Three  me thods  have  been  deve loped  fo r 
determination of DEC in bulk drug and in its dosage 
forms and validated as per the current ICH guidelines. 
The methods use cheap and readily available chemicals, 
compared to the lone titrimetric method [official method], 
the presented methods are rather simple and sensitive. The 
reported methods suffer from such draw backs as high 
cost, and several clean-up steps. They are time-consuming 
and often poorly reproducible, some require toxic organic 
solvents. Any method chosen for routine analysis should 
be reasonably simple, used materials should be readily 
available in the laboratory or readily obtainable, and 
require a minimum amount of equipment. The methods are 
selective as none of the common tablet excipients contain 
acidic groups to interfere with the present proposed 
methods. The proposed spectrophotometric methods are 
free from rigid experimental variables such as pH control, 
heating or extraction step and/or use of organic solvents. 
They are characterized by high selectivity and comparable 
sensitivity with respect to the existing methods (Table V).
TABLE V - Comparison of performance characteristics of the present methods with the existing methods
Sl. No. Reagent/s used Methodology lmax  (nm)
Linear range 
 (mg/mL-1) 
e (L mol-1cm-1)
Remarks Ref. No.
1 *CAA
Measurement 
of purple color 
CT complex in 
dioxane-CHCl3
540 10-400 Mixture of organic solvents used
Michael, 
Kenneth, 
Anthony, 1999
2 Ammonium reineckate
Absorbance of 
red color product 
at pH=3.5 in 
acetone measured 
525 -
Tedious and time consuming, 
Pptn washing and dissolution 
steps involved
Basu, Dutta, 
1961
3 Malonic acid-acetic anhydride
Measurement 
of absorption 
of condensation 
product 
333 - Heating step and longer contact time involved
Refaat et al., 
1987
4 Malonic acid-acetic anhydride
Measurement 
of absorption 
of condensation 
product
334 0-4 Heating step, longer contact time and ethanol as diluent
Bulbule, Kasture, 
Wadodkar,1981
5 HOAc-Ac2O and pyridine
Absorbance of 
yellow color 
product measured
428 10-110 Heating step and longer contact time involved
Bhuee et al., 
1981
6 *BPB
Extracted ion-
pair complex 
measured 
- -
Tedious and time consuming 
extraction step and critical pH 
adjustment involved
Rao, 
Subrahmanyam, 
1970
7 *BCG
Yellow ion-
pair complex 
measured in 
chloroform
- -
Tedious and time consuming 
extraction step and critical pH 
adjustment involved
Vadodaria, Vora, 
Mukherji, 1968
8 a) Fast green FCF b) orange- II
Ion-pair complex 
extracted into 
chloroform and 
measured
- -
Tedious and time consuming 
extraction step and critical pH 
adjustment involved
Sastry et al., 
1988
9
a) KI-KIO3
Measurement of 
liberated iodine 370
2.5–50 
6.48×103 Rapid, no heating or 
extraction step involved, 
selective, sensitive with wide 
linear dynamic range, used 
aqueous medium
Present work
b) KI-KIO3 and 
starch
Absorbance of 
blue color iodine-
starch complex 
measured
570 2.5–30 9.96×103
* CAA-chloranilic acid, BCG-bromocresol green, BPB-bromophenol blue, BTB-bromothymol blue
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